Matteo Di Biase Selected Research

Percutaneous Coronary Intervention

9/2021	Revascularization rates with coronary angioplasty and mortality in type 2 myocardial infarction: A meta-regression analysis.
1/2018	QT-interval evaluation in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction for prediction of myocardial salvage index.
1/2018	Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis.
1/2017	Optimal duration of dual anti-platelet therapy after percutaneous coronary intervention: 2016 consensus position of the Italian Society of Cardiology.
9/2014	Pre-hospital electrocardiogram triage with tele-cardiology support is associated with shorter time-to-balloon and higher rates of timely reperfusion even in rural areas: data from the Bari- Barletta/Andria/Trani public emergency medical service 118 registry on primary angioplasty in ST-elevation myocardial infarction.
6/2012	Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.
10/2008	Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention.
8/2007	Inflammatory cytokine imbalance after coronary angioplasty: links with coronary atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matteo Di Biase Research Topics

Disease

29	Heart Failure 10/2023 - 04/2008
21	Takotsubo Cardiomyopathy 01/2023 - 08/2012
17	Acute Coronary Syndrome 12/2020 - 05/2006
13	Atrial Fibrillation 11/2020 - 03/2005
12	Myocardial Infarction 01/2022 - 12/2008
11	Pulmonary Hypertension 10/2020 - 10/2011
11	Coronary Artery Disease (Coronary Atherosclerosis) 08/2020 - 08/2007
8	Hemorrhage 08/2020 - 11/2012
7	ST Elevation Myocardial Infarction 12/2020 - 12/2008
6	Thrombosis (Thrombus) 01/2022 - 04/2012
5	Pulmonary Arterial Hypertension 06/2020 - 12/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 07/2018 - 04/2008
5	Left Ventricular Dysfunction 02/2018 - 01/2011
5	Atherosclerosis 01/2017 - 05/2003
4	Neoplasms (Cancer) 08/2020 - 12/2014
4	Hypertension (High Blood Pressure) 07/2016 - 01/2009
4	Chest Pain (Chest Pains) 01/2014 - 12/2008
3	Cardiogenic Shock 01/2023 - 10/2017
3	Diabetes Mellitus 12/2022 - 08/2009
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 10/2009
3	Embolism (Embolus) 08/2020 - 03/2017
3	Congenital Heart Defects (Congenital Heart Defect) 03/2019 - 01/2009
3	Dyslipidemias (Dyslipidemia) 09/2018 - 01/2017
3	Pulmonary Embolism 06/2012 - 04/2008
2	Heart Diseases (Heart Disease) 06/2021 - 12/2013
2	Fibrosis (Cirrhosis) 06/2021 - 08/2016
2	Hodgkin Disease (Hodgkin's Disease) 03/2019 - 05/2013
2	Syncope (Fainting) 03/2019 - 04/2013
2	Coronary Disease (Coronary Heart Disease) 09/2018 - 02/2012
2	Pulmonary Edema 07/2018 - 02/2012
2	Carotid Artery Diseases 09/2017 - 01/2015
2	Spasm (Spasms) 12/2016 - 06/2012
2	Ventricular Tachycardia 12/2016 - 11/2016
2	Pathologic Constriction (Stenosis) 07/2016 - 10/2006
2	Sepsis (Septicemia) 10/2015 - 06/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2014 - 10/2011
2	Atherosclerotic Plaque (Atheroma) 01/2014 - 05/2003
2	Infarction (Infarctions) 01/2014 - 10/2008
2	Cardiac Arrhythmias (Arrythmia) 05/2013 - 03/2005
2	Brugada Syndrome 04/2013 - 04/2008
1	Philadelphia Chromosome 04/2022

Drug/Important Bio-Agent (IBA)

8	AnticoagulantsIBA 11/2020 - 01/2016
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2014
6	TroponinIBA 12/2017 - 04/2008
5	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2023 - 03/2019
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2017 - 03/2005
5	Interleukin-6 (Interleukin 6)IBA 09/2017 - 01/2011
5	CytokinesIBA 10/2014 - 09/2006
5	C-Reactive ProteinIBA 12/2012 - 05/2006
4	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2018 - 07/2008
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2012 - 10/2008
3	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023 - 12/2022
3	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 08/2009
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 07/2016
3	Troponin IIBA 12/2020 - 10/2008
3	LipidsIBA 09/2018 - 07/2016
3	IvabradineIBA 10/2017 - 12/2012
3	Sildenafil Citrate (Viagra)FDA Link 10/2016 - 06/2012
3	Antihypertensive Agents (Antihypertensives)IBA 07/2016 - 06/2011
3	Interleukin-10 (Interleukin 10)IBA 04/2014 - 08/2007
3	InterleukinsIBA 02/2012 - 09/2006
2	GadoliniumIBA 06/2021 - 08/2016
2	CatecholaminesIBA 12/2020 - 12/2013
2	Warfarin (Coumadin)FDA LinkGeneric 08/2020 - 03/2017
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2020 - 03/2017
2	Clostridium perfringens epsilon-toxinIBA 06/2020 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 03/2019 - 12/2008
2	macitentanIBA 09/2018 - 10/2016
2	Fenofibrate (CiL)FDA LinkGeneric 09/2018 - 01/2017
2	Vitamin K FDA Link 05/2018 - 03/2017
2	CoagulantsIBA 05/2018 - 03/2017
2	Angiotensin Receptor AntagonistsIBA 03/2017 - 07/2016
2	Simvastatin (Zocor)FDA LinkGeneric 01/2017 - 09/2015
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2016 - 03/2016
2	Simendan (Levosimendan)IBA 01/2016 - 12/2013
2	Atorvastatin (Lipitor)FDA Link 09/2015 - 02/2012
2	Tryptases (Tryptase)IBA 01/2015 - 01/2014
2	Interleukin-8 (Interleukin 8)IBA 04/2014 - 02/2012
2	Tenecteplase FDA Link 01/2014 - 08/2009
2	Anti-Arrhythmia AgentsIBA 11/2013 - 03/2005
2	CarbohydratesIBA 04/2012 - 06/2009
2	AntibodiesIBA 10/2010 - 05/2003
2	AntigensIBA 06/2009 - 05/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2007 - 09/2006
1	Sodium-Glucose Transport ProteinsIBA 10/2023
1	SodiumIBA 08/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2022
1	Imatinib Mesylate (Gleevec)FDA Link 04/2022

Therapy/Procedure

29	Therapeutics 01/2023 - 01/2011
8	Percutaneous Coronary Intervention 09/2021 - 08/2007
6	Drug Therapy (Chemotherapy) 01/2022 - 10/2011
5	Stents 01/2018 - 06/2012
4	Length of Stay 10/2017 - 12/2013
4	Patient Readmission 10/2015 - 01/2011
3	Catheter Ablation 01/2020 - 07/2013
2	Electric Countershock (Cardioversion) 05/2018 - 08/2013
2	Time-to-Treatment 04/2017 - 11/2011
2	Radiotherapy 12/2014 - 05/2013
1	Counterpulsation (External Counterpulsation) 01/2023